We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IMRX market cap is 46.56M. The company's latest EPS is USD -1.8260 and P/E is -0.84.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 38k | 1,000 | 0 | 0 | 0 |
| Operating Income | -13.19M | -13.99M | -14.68M | -13.51M | -13.93M |
| Net Income | -12.84M | -13.25M | -13.6M | -12.19M | -12.6M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.92M | 2.31M | 2.08M | 317k | 0 |
| Operating Income | -6.29M | -17.08M | -33.89M | -51.75M | -58.41M |
| Net Income | -7.71M | -17.04M | -33.54M | -50.51M | -53.47M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 133.69M | 122.37M | 107.7M | 124.9M | 113.88M |
| Total Liabilities | 11.8M | 12.52M | 9.91M | 9.79M | 9.86M |
| Total Equity | 121.89M | 109.85M | 97.79M | 115.1M | 104.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.1M | 38.42M | 166.71M | 122.37M | 102.59M |
| Total Liabilities | 4.02M | 2.8M | 10.73M | 12.52M | 12.01M |
| Total Equity | -6.53M | -22.48M | 155.98M | 109.85M | 90.58M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.35M | -44.1M | -14.42M | -25.17M | -37.19M |
| Investing | 33.68M | 41.83M | 18.97M | 28.14M | 4.16M |
| Financing | 204k | 19k | 239k | 28.41M | 28.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.44M | -14.62M | -30.85M | -44.1M | -48.97M |
| Investing | -21k | -53k | -75.62M | 41.83M | 7.3M |
| Financing | 17.17M | 37.98M | 144.27M | 19k | 28.44M |
| Market Cap | 46.56M |
| Price to Earnings Ratio | -0.84 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.75 |
| Price to Book Ratio | 0.49 |
| Dividend Yield | - |
| Shares Outstanding | 29.28M |
| Average Volume (1 week) | 463.77k |
| Average Volume (1 Month) | 518.6k |
| 52 Week Change | -85.56% |
| 52 Week High | 11.92 |
| 52 Week Low | 1.38 |
| Spread (Intraday) | 0.08 (4.88%) |
| Company Name | Immuneering Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.immuneering.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
